tradingkey.logo
tradingkey.logo
Buscar

Treace Medical Concepts Inc

TMCI
Añadir a la lista de seguimiento
4.210USD
-0.020-0.47%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
272.75MCap. mercado
PérdidaP/E TTM

Más Datos de Treace Medical Concepts Inc Compañía

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Información de Treace Medical Concepts Inc

Símbolo de cotizaciónTMCI
Nombre de la empresaTreace Medical Concepts Inc
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoTreace (John T)
Número de empleados477
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 23
Dirección100 Palmetto Park Place
CiudadPONTE VEDRA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32081
Teléfono19043735940
Sitio Webhttps://www.treace.com/
Símbolo de cotizaciónTMCI
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoTreace (John T)

Ejecutivos de Treace Medical Concepts Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Treace Medical Concepts Inc?

Los cinco principales accionistas de Treace Medical Concepts Inc son: Mr. John K. Bakewell

¿Cuántas instituciones poseen acciones de Treace Medical Concepts Inc (TMCI)?

A fecha de 2026Q1, 342 instituciones poseen acciones de Treace Medical Concepts Inc, con un valor de mercado combinado de aproximadamente 37.97M, lo que representa el 58.61% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -15683733.00.